CN102784296A - Fructus trichosanthis oral liquid - Google Patents

Fructus trichosanthis oral liquid Download PDF

Info

Publication number
CN102784296A
CN102784296A CN201210304244XA CN201210304244A CN102784296A CN 102784296 A CN102784296 A CN 102784296A CN 201210304244X A CN201210304244X A CN 201210304244XA CN 201210304244 A CN201210304244 A CN 201210304244A CN 102784296 A CN102784296 A CN 102784296A
Authority
CN
China
Prior art keywords
radix
oral liquid
neurodermatitis
leukoplakia
psoriasis vulgaris
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201210304244XA
Other languages
Chinese (zh)
Other versions
CN102784296B (en
Inventor
徐海波
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 201210304244 priority Critical patent/CN102784296B/en
Publication of CN102784296A publication Critical patent/CN102784296A/en
Application granted granted Critical
Publication of CN102784296B publication Critical patent/CN102784296B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a new traditional Chinese medicine oral liquid for treating psoriasis vulgaris as the main, and chronic simple lichen (neurodermatitis) and vulval leukoplakia, which is mainly prepared from 12 traditional Chinese medicine components, such as fructus trichosanthis and fructus mume. The oral liquid has certain curative effect for psoriasis vulgaris, chronic simple lichen (neurodermatitis) and vulval leukoplakia. The oral liquid is scientific in prescription and significant in curative effect.

Description

The Fructus Trichosanthis oral liquid
Technical field
The present invention relates to a kind of treatment and with the psoriasis vulgaris be the oral medicine of main and chronic simple lichen (neurodermatitis), leukoplakia of vulva, specifically is the oral liquid of feedstock production with the Chinese herbal medicine.
Background technology
Motherland's medical science is such description to psoriasis vulgaris, chronic simple lichen (neurodermatitis), leukoplakia of vulva: the wanting of negative and positive, sun is close to be solid.YIN and YANG in a relative equilibrium, life activities being normally maintained.Seasonal pathogens,exopathogens, the growth of wood fire department, the collection of Jinsui River department.Prevailing of the wind then edema with the liver involved sparrow hawk is opened, the order of lumber yard catharsis, and the power of golden misconvergence, and pathogenic wind is too prosperous, does not receive the gold system, the anti-gold of insulting; Gold gas loses to be received, and clear respectful not all right, gold is a Jellyfish, and aqueous vapor is lost root, the withered consumption of body fluid; The moon decreases in down, and the duty of keeping in losing, and then sun is lonely in last, and it is dry that lung is suffered from, and the dryness of the lung is then itched.Always treat the case of psoriasis vulgaris, chronic simple lichen (neurodermatitis), leukoplakia of vulva many with diverging and dispelling wind-evil for controlling, but do not see desirable, the authoritative medicament appearance of potion curative effect so far.
Summary of the invention
The object of the present invention is to provide a kind of is the oral medicine of master and chronic simple lichen (neurodermatitis), leukoplakia of vulva with the treatment psoriasis vulgaris; Its disease for skin pruritus, rough surface plumpness provides a kind of convenience, effective, oral medicine without any side effects " oral liquid ".
Solution of the present invention is that the inventor is based on psoriasis vulgaris, chronic simple lichen (neurodermatitis), leukoplakia of vulva in motherland's theory of medicine: the relatively catharsis of person wood fire, and golden gas is dashed and the order of misconvergence, and aqueous vapor is let out; And the ability of mistake envelope Tibetan; The water not then mutually fiery beneficial thing of intrinsic energy is soared, and the Jin Bushou then beneficial thing of wind wood lets out, and the part of the body cavity above the diaphragm housing the heart and lungs then body fluid is hindered and the steam extrusion; The part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels then mutually fire let out and order hollow, middle Jiao then in weakness of QI lose and hand over Ji incompetent.Wind and vital-QI fighting each other, prevailing of the wind then are urticaria, and health is for itching itching being called wind-leaking, itching caused by urticaria lasting a long time leading to scabs and tinea.So medical scheme of taking: " liver is bitter anxious, anxious food sweet flavor has the effect of relaxing, acid is rushed down it, fit its property and decline also." slow liver is suddenly with endogenous wind stopping, lung moistening is dry to make wood.
The clinical experience that the inventor summed up 14 years think because of follow " liver is bitter anxious, anxious food sweet flavor has the effect of relaxing, acid is rushed down it, fit its property and decline also." theory, from many cases psoriasis vulgaris, chronic simple lichen (neurodermatitis), leukoplakia of vulva patient, progressively grope to sum up its Therapeutic Principle: slow liver is anxious with endogenous wind stopping, and lung moistening is dry to make wood.Relevant theoretical in conjunction with motherland's medical science; Having drawn motherland's medical science selectively has the prescription elite of related disorders, filters out the prescription of the Chinese herbal medicine science of significant curative effect, develops the Chinese medicine oral liquid of specially controlling psoriasis vulgaris, chronic simple lichen (neurodermatitis), leukoplakia of vulva; Its clinical manifestation is gone out: skin pruritus, the disease that rough surface is plump; Treat targetedly, reach ideal curative effect, the wood invention is processed (consumption is a unit of weight) by following component.
Fructus Trichosanthis 20-25 Fructus Mume 20-25 Rhizoma Dioscoreae 10-15
Radix Ophiopogonis 10-15 Bulbus Lilii 10-15 Rhizoma Polygonati Odorati 10-15
Radix Angelicae Sinensis 10-15 Radix Paeoniae Alba 10-15 Rhizoma Pinelliae Preparatum 10-15
Flos Sophorae 10-15 Radix Glehniae 10-15 Radix Glycyrrhizae 10-15
Medical material weight of the present invention (part) proportioning is:
12 Radix Ophiopogonis 12 of Fructus Trichosanthis 24 Fructus Mumes 24 Rhizoma Dioscoreaes
Bulbus Lilii 12 Rhizoma Polygonati Odorati 12 Radix Angelicae Sinensis 12 Radix Paeoniae Albas 12
Rhizoma Pinelliae Preparatum 12 Flos Sophoraes 12 Radix Glehniaes 12 Radix Glycyrrhizae 12
Processing method for preparing of the present invention by above-mentioned each component is:
1, each raw material of Chinese medicine medicine in the prescription is decocted method by conventional Chinese medicine and fry in shallow oil back concentrating;
2, medicinal liquid is sealed up for safekeeping well by every 20ml fill with filling machine.
Fructus Trichosanthis oral liquid of the present invention has following advantage:
Can make psoriasis vulgaris, chronic simple lichen (neurodermatitis), leukoplakia of vulva at short notice skin lesion disappear more than 30%; Chronic simple lichen (neurodermatitis), leukoplakia of vulva after two courses of treatment skin lesion disappear and reach 80%-90%, other transference cures.Psoriasis vulgaris 3-5 month clinical cure need not auxiliary therapy.Fructus Trichosanthis in the side, sweet cold, suppressing the hyperactive liver emergency, elimination Liang Run; Fructus Mume, acid is flat, and sour and astringent convergence, acid are rushed down wind wood and are ended catharsis with the eliminating pathogen in the liver tonifying the lung; Share with Fructus Trichosanthis, is principal agent altogether.Rhizoma Dioscoreae, sweet flat, the QI invigorating tonifying the lung, yin nourishing is good for the stomach, the dry only catharsis of endogenous wind stopping; Radix Ophiopogonis, sweet flat, reinforcing stomach reg fluid, nourishing lung-YIN: Bulbus Lilii, sweet flat, invigorating the spleen and replenishing QI, clearing heat in the lung is moisturized; Rhizoma Polygonati Odorati, sweet flat, the nourishing the stomach of promoting the production of body fluid, nourishing YIN and moistening the lung is mended golden endogenous wind stopping; Radix Angelicae Sinensis, sweet, enrich blood and invigorate blood circulation, moisten sliding pool; The Radix Paeoniae Alba, bitter flat, the yin fluid astringing that nourishes blood, the suppressing the hyperactive liver easing the affected liver, fresh breeze is dry and hold back catharsis, makes the liver blood foot and wind is fixed; Be ministerial drug altogether.Rhizoma Pinelliae Preparatum, hot flat, fall and take the photograph gastric qi, therapeutic method to keep the adverse QI flowing downwards stomach function regulating, and then do not dislike it dry with a large amount of clear and rich compatibility of drugss: Flos Sophorae, hardship is slightly cold, and removing heat from blood fresh breeze is controlled the scabies skin wind of dispelling; Radix Glehniae, hardship is slightly cold, reinforcing stomach reg fluid, clearing lung and nourishing yin, mediation and not dry, moist and do not stagnate; Be adjuvant drug altogether.Radix Glycyrrhizae, sweet flat, relax the property of medicine, coordinating the actions of various ingredients in a prescription is a messenger drug.
Use pharmaceutical methods of the present invention: each one (20ml), every day three times, taking medicine before meal.Ten days courses of treatment of chronic simple lichen (neurodermatitis), leukoplakia of vulva, month course of treatment of psoriasis vulgaris, totally three to five courses of treatment.
For showing the therapeutic effect of medicine of the present invention to psoriasis vulgaris, chronic simple lichen (neurodermatitis), leukoplakia of vulva; The present invention is through the clinical observation of 100 routine systems; Wherein: psoriasis vulgaris 60 examples; Chronic simple lichen (neurodermatitis), each 20 example of leukoplakia of vulva, and selection medical history, the state of an illness, age, sex and suitable psoriasis vulgaris, chronic simple lichen (neurodermatitis), leukoplakia of vulva patient 73 examples of former treatment are matched group.From being in hospital and special outpatient clinic; Select case, according to " the disease of tcm diagnosis criterion of therapeutical effect " of State Administration of Traditional Chinese Medicine's formulation in 1994, the psoriasis vulgaris of making a definite diagnosis, chronic simple lichen (neurodermatitis), leukoplakia of vulva patient are the object of observation; Male's 50 examples wherein; Women's 50 examples, age 18-70 year, the course of disease is from starting phase to 20 year.Test group: on use or basis, discontinue medication, take medicine of the present invention without the initial stage medicine for external use.Matched group: use medicine for external use commonly used by conventional treatments, and in, western oral medicine.Two of medicine for external use group usage, consumption are complementary, 12 months observation periods, ten days courses of treatment of chronic simple lichen (neurodermatitis), leukoplakia of vulva, month course of treatment of psoriasis vulgaris, totally three courses of treatment.
Use pharmaceutical methods of the present invention: one day three, each (20ml) oral liquid, ante cibum is oral.A month course of treatment.
Test group, matched group, after three months courses of treatment, the curative effect situation sees the following form:
The curative effect information slip
Figure BSA00000768175600031
After showing to find out that test group is taken medicine of the present invention, cardinal symptom disappears, and skin lesion disappears, and therapeutic effect is obvious.Clinical 14 years of inventor, accept 200 for medical treatment surplus example, effective percentage 95% (wherein cure rate 82%), inefficiency 5%.
The specific embodiment
Embodiment.Psoriasis vulgaris, chronic simple lichen (neurodermatitis), executing of leukoplakia of vulva are controlled.
1, the composition of medicine and proportioning:
Fructus Trichosanthis 24g Fructus Mume 24g Rhizoma Dioscoreae 12g 12g Radix Ophiopogonis
Bulbus Lilii 12g Rhizoma Polygonati Odorati 12g Radix Angelicae Sinensis 12g Radix Paeoniae Alba 12g
Rhizoma Pinelliae Preparatum 12g Flos Sophorae 12g Radix Glehniae 12g Radix Glycyrrhizae 12g
2, manufacture method and use:
With each raw material of Chinese medicine medicine in the prescription, by conventional Chinese medicine fry in shallow oil, the method for enduring fries in shallow oil; Medicinal liquid is irritated by every 20ml with filling machine, seal up for safekeeping.One day three, each (20ml) oral liquid, ante cibum is oral, ten days courses of treatment of chronic simple lichen (neurodermatitis), leukoplakia of vulva month course of treatment of psoriasis vulgaris adheres to using, and does not recur more than 10 years.

Claims (2)

1. Chinese medicine oral liquid of treating psoriasis vulgaris is characterized in that each raw material is formed, weight proportion is:
Fructus Trichosanthis 20-25 Fructus Mume 20-25 Rhizoma Dioscoreae 10-15
Radix Ophiopogonis 10-15 Bulbus Lilii 10-15 Rhizoma Polygonati Odorati 10-15
Radix Angelicae Sinensis 10-15 Radix Paeoniae Alba 10-15 Rhizoma Pinelliae Preparatum 10-15
Flos Sophorae 10-15 Radix Glehniae 10-15 Radix Glycyrrhizae 10-15.
2. Chinese medicine oral liquid according to claim 1, wherein each raw material weight proportioning is:
Fructus Trichosanthis 24g Fructus Mume 24g Rhizoma Dioscoreae 12g 12g Radix Ophiopogonis
Bulbus Lilii 12g Rhizoma Polygonati Odorati 12g Radix Angelicae Sinensis 12g Radix Paeoniae Alba 12g
Rhizoma Pinelliae Preparatum 12g Flos Sophorae 12g Radix Glehniae 12g Radix Glycyrrhizae 12g.
CN 201210304244 2012-08-19 2012-08-19 Fructus trichosanthis oral liquid Expired - Fee Related CN102784296B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201210304244 CN102784296B (en) 2012-08-19 2012-08-19 Fructus trichosanthis oral liquid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201210304244 CN102784296B (en) 2012-08-19 2012-08-19 Fructus trichosanthis oral liquid

Publications (2)

Publication Number Publication Date
CN102784296A true CN102784296A (en) 2012-11-21
CN102784296B CN102784296B (en) 2013-12-18

Family

ID=47150014

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201210304244 Expired - Fee Related CN102784296B (en) 2012-08-19 2012-08-19 Fructus trichosanthis oral liquid

Country Status (1)

Country Link
CN (1) CN102784296B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106822665A (en) * 2017-04-11 2017-06-13 李梦 Chinese medicine composition and medicament and preparation method for treating psoriasis
EP3363450A4 (en) * 2015-10-15 2019-04-10 Guangdong Provincial Hospital Of Chinese Medicine Traditional chinese medicine composition for treating psoriasis

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1223870A (en) * 1998-01-22 1999-07-28 唐山市京东皮肤病研究所 Psoriasis capsule
CN102210811A (en) * 2011-05-27 2011-10-12 徐海波 Dark plum oral solution

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1223870A (en) * 1998-01-22 1999-07-28 唐山市京东皮肤病研究所 Psoriasis capsule
CN102210811A (en) * 2011-05-27 2011-10-12 徐海波 Dark plum oral solution

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
国家药典委员会: "《中华人民共和国药典2010年版 一步》", 31 December 2010, article "槐花、法半夏", pages: 333-334 - 111 *
王远红等: "中医药治疗银屑病分型治疗综述", 《中医药学报》, vol. 35, no. 3, 31 August 2007 (2007-08-31), pages 47 - 49 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3363450A4 (en) * 2015-10-15 2019-04-10 Guangdong Provincial Hospital Of Chinese Medicine Traditional chinese medicine composition for treating psoriasis
CN106822665A (en) * 2017-04-11 2017-06-13 李梦 Chinese medicine composition and medicament and preparation method for treating psoriasis

Also Published As

Publication number Publication date
CN102784296B (en) 2013-12-18

Similar Documents

Publication Publication Date Title
CN103120791B (en) A kind of Chinese medicine composition for the treatment of viral myocarditis and preparation method thereof
CN102210811B (en) Dark plum oral solution
CN103301386B (en) Pill for treating qi failing to consolidate semen and preparation method thereof
CN102784296B (en) Fructus trichosanthis oral liquid
CN106214986A (en) A kind of Chinese medicine decoction treating cardiovascular and cerebrovascular disease
CN103127325A (en) Traditional Chinese medicine compound for treatment of hepatitis and preparation method thereof
CN102949685A (en) Traditional Chinese medicine composition for treating chronic gastritis
CN102327436A (en) Traditional Chinese medicine composition for treating edema during menstruation
CN104758845A (en) External traditional Chinese medicine ointment for treating scapulohumeral periarthritis
CN103110811B (en) Traditional Chinese medicine composition for treating arrhythmia
CN103599430B (en) A kind of Chinese medicine composition being used for the treatment of cardiac asthma
CN102764374B (en) Traditional Chinese medicine powder for treating peptic ulcer
CN102018882A (en) Chinese medicinal composition for treating lumbago
CN103191281B (en) Dried rehamnnia root oral liquid
CN101716326B (en) Medicament for treating children chronic cough and allergic rhinitis and preparation method thereof
CN104606399A (en) Traditional Chinese medicine ointment for treating scleroderma and preparation method of Traditional Chinese medicine ointment
CN102885952B (en) South dodder seed oral liquid
CN103463463A (en) Traditional Chinese medicine preparation for replenishing and activating blood and dispelling wind and removing dampness
CN104161922A (en) Traditional Chinese medicine for treating qi deficiency-type cough
CN108079073A (en) It is a kind of steep pedicure tremble with fear foot alleviate medicine Chinese medicine powder
CN103611009B (en) A kind of Chinese medicine composition for caused by hepatic stagnation qi stagnation lactogenic in puerperal
CN103007211A (en) Traditional Chinese medicine preparation for treating primary vaginal dripping
CN106074784A (en) The Chinese medicine for the treatment of coronary heart disease and myocardial ischemia
CN105267862A (en) Traditional Chinese medicine composition for treating ventricular premature beat
CN105169324A (en) Chinese herba preparation for prevention and treatment of common cold due to wind-cold

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20131218

Termination date: 20200819